The New Investigator Gateway Awards for Collaborative T1D Research (R03) is a funding opportunity from the National Institutes of Health (NIH), specifically through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of The Director (OD). The program aims to support a robust pipeline of innovative projects and new investigators in type 1 diabetes (T1D) research, focusing on understanding T1D mechanisms, prevention, treatment, and cure. Awardees will be embedded within large, established research consortia such as HIRN, TrialNet, TEDDY, DFC, and CaRe-T1D to promote collaboration, networking, and career advancement. Clinical trials are not allowed for this opportunity. Applicants must target research topics aligned with the scientific priorities of these consortia and address key barriers in T1D research.
The New Investigator Gateway Awards for Collaborative T1D Research (R03) is a funding opportunity from the National Institutes of Health (NIH), specifically through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of The Director (OD). The program aims to support a robust pipeline of innovative projects and new investigators in type 1 diabetes (T1D) research, focusing on understanding T1D mechanisms, prevention, treatment, and cure. Awardees will be embedded within large, established research consortia such as HIRN, TrialNet, TEDDY, DFC, and CaRe-T1D to promote collaboration, networking, and career advancement. Clinical trials are not allowed for this opportunity. Applicants must target research topics aligned with the scientific priorities of these consortia and address key barriers in T1D research.